CA2148140C - Homogeneous method for assay of double-stranded nucleic acids using fluorescent dyes and kit useful therein - Google Patents

Homogeneous method for assay of double-stranded nucleic acids using fluorescent dyes and kit useful therein Download PDF

Info

Publication number: CA2148140C
Authority: CA; Canada
Prior art keywords: carbon atoms; nucleic acid; double; target nucleic; alkyl
Prior art date: 1994-04-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA2148140A

Other languages

English (en)

French (fr)

Other versions

CA2148140A1 (en

Inventor

John W. Sutherland

David R. Patterson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ortho Clinical Diagnostics Inc

Original Assignee

Ortho Clinical Diagnostics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-04-29

Filing date

1995-04-28

Publication date

2010-08-10

1995-04-28 Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc

1995-10-30 Publication of CA2148140A1 publication Critical patent/CA2148140A1/en

2010-08-10 Application granted granted Critical

2010-08-10 Publication of CA2148140C publication Critical patent/CA2148140C/en

2015-04-28 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

150000007523 nucleic acids Chemical class 0.000 title claims abstract description 92
108020004707 nucleic acids Proteins 0.000 title claims abstract description 90
102000039446 nucleic acids Human genes 0.000 title claims abstract description 90
239000007850 fluorescent dye Substances 0.000 title claims abstract description 43
238000000034 method Methods 0.000 title claims description 60
238000003556 assay Methods 0.000 title abstract description 18
230000003321 amplification Effects 0.000 claims abstract description 77
238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 77
239000000975 dye Substances 0.000 claims abstract description 70
238000001514 detection method Methods 0.000 claims abstract description 31
238000003752 polymerase chain reaction Methods 0.000 claims abstract description 31
239000003153 chemical reaction reagent Substances 0.000 claims abstract description 13
ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 claims abstract description 6
125000004432 carbon atom Chemical group C* 0.000 claims description 47
239000000523 sample Substances 0.000 claims description 34
125000000217 alkyl group Chemical group 0.000 claims description 28
102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 22
108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 21
239000011541 reaction mixture Substances 0.000 claims description 15
238000012360 testing method Methods 0.000 claims description 14
125000002947 alkylene group Chemical group 0.000 claims description 12
239000012807 PCR reagent Substances 0.000 claims description 11
238000006243 chemical reaction Methods 0.000 claims description 11
229910052739 hydrogen Inorganic materials 0.000 claims description 11
239000001257 hydrogen Substances 0.000 claims description 11
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
238000012544 monitoring process Methods 0.000 claims description 10
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
150000001450 anions Chemical class 0.000 claims description 9
229910052799 carbon Inorganic materials 0.000 claims description 9
125000005842 heteroatom Chemical group 0.000 claims description 9
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
125000003118 aryl group Chemical group 0.000 claims description 7
239000002253 acid Substances 0.000 claims description 6
BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 claims description 5
125000005605 benzo group Chemical group 0.000 claims description 5
IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical group C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 claims description 5
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 5
125000002373 5 membered heterocyclic group Chemical group 0.000 claims description 4
125000004070 6 membered heterocyclic group Chemical group 0.000 claims description 4
238000009396 hybridization Methods 0.000 claims description 2
238000004806 packaging method and process Methods 0.000 claims description 2
229940126062 Compound A Drugs 0.000 claims 3
NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims 3
108020004414 DNA Proteins 0.000 description 28
150000001875 compounds Chemical class 0.000 description 13
239000002773 nucleotide Substances 0.000 description 13
125000003729 nucleotide group Chemical group 0.000 description 12
239000000243 solution Substances 0.000 description 11
239000000872 buffer Substances 0.000 description 8
-1 deoxyribonucleotide triphosphates Chemical class 0.000 description 8
239000000463 material Substances 0.000 description 8
239000000203 mixture Substances 0.000 description 8
ULHRKLSNHXXJLO-UHFFFAOYSA-L Yo-Pro-1 Chemical compound [I-].[I-].C1=CC=C2C(C=C3N(C4=CC=CC=C4O3)C)=CC=[N+](CCC[N+](C)(C)C)C2=C1 ULHRKLSNHXXJLO-UHFFFAOYSA-L 0.000 description 7
GRRMZXFOOGQMFA-UHFFFAOYSA-J YoYo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3O2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2O1 GRRMZXFOOGQMFA-UHFFFAOYSA-J 0.000 description 7
238000004925 denaturation Methods 0.000 description 7
230000036425 denaturation Effects 0.000 description 7
125000000623 heterocyclic group Chemical group 0.000 description 7
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
102000004190 Enzymes Human genes 0.000 description 6
108090000790 Enzymes Proteins 0.000 description 6
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
230000000692 anti-sense effect Effects 0.000 description 6
230000015572 biosynthetic process Effects 0.000 description 6
230000000295 complement effect Effects 0.000 description 6
239000002245 particle Substances 0.000 description 6
239000007853 buffer solution Substances 0.000 description 5
238000001816 cooling Methods 0.000 description 5
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 5
229960005542 ethidium bromide Drugs 0.000 description 5
230000005284 excitation Effects 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
239000000126 substance Substances 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
230000000694 effects Effects 0.000 description 4
239000000499 gel Substances 0.000 description 4
238000010438 heat treatment Methods 0.000 description 4
239000003068 molecular probe Substances 0.000 description 4
230000037452 priming Effects 0.000 description 4
239000007787 solid Substances 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
239000001226 triphosphate Substances 0.000 description 4
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 3
229920000936 Agarose Polymers 0.000 description 3
241000894006 Bacteria Species 0.000 description 3
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical class [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 3
PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 3
108091034117 Oligonucleotide Proteins 0.000 description 3
DPXHITFUCHFTKR-UHFFFAOYSA-L To-Pro-1 Chemical compound [I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 DPXHITFUCHFTKR-UHFFFAOYSA-L 0.000 description 3
QHNORJFCVHUPNH-UHFFFAOYSA-L To-Pro-3 Chemical compound [I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=CC=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 QHNORJFCVHUPNH-UHFFFAOYSA-L 0.000 description 3
241000700605 Viruses Species 0.000 description 3
230000002411 adverse Effects 0.000 description 3
239000008366 buffered solution Substances 0.000 description 3
210000004027 cell Anatomy 0.000 description 3
238000011109 contamination Methods 0.000 description 3
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 3
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 3
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 3
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 3
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 3
230000001419 dependent effect Effects 0.000 description 3
238000010790 dilution Methods 0.000 description 3
239000012895 dilution Substances 0.000 description 3
238000011534 incubation Methods 0.000 description 3
239000012678 infectious agent Substances 0.000 description 3
238000007834 ligase chain reaction Methods 0.000 description 3
239000011572 manganese Substances 0.000 description 3
241000894007 species Species 0.000 description 3
238000010186 staining Methods 0.000 description 3
150000003467 sulfuric acid derivatives Chemical class 0.000 description 3
XJCQPMRCZSJDPA-UHFFFAOYSA-L trimethyl-[3-[4-[(e)-(3-methyl-1,3-benzothiazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]azanium;diiodide Chemical compound [I-].[I-].S1C2=CC=CC=C2N(C)\C1=C\C1=CC=[N+](CCC[N+](C)(C)C)C=C1 XJCQPMRCZSJDPA-UHFFFAOYSA-L 0.000 description 3
HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 2
102000053602 DNA Human genes 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
108010090804 Streptavidin Proteins 0.000 description 2
241000589500 Thermus aquaticus Species 0.000 description 2
MZZINWWGSYUHGU-UHFFFAOYSA-J ToTo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3S2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2S1 MZZINWWGSYUHGU-UHFFFAOYSA-J 0.000 description 2
150000001242 acetic acid derivatives Chemical class 0.000 description 2
DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
125000002837 carbocyclic group Chemical group 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
238000007705 chemical test Methods 0.000 description 2
150000001805 chlorine compounds Chemical class 0.000 description 2
238000010367 cloning Methods 0.000 description 2
JNGZXGGOCLZBFB-IVCQMTBJSA-N compound E Chemical compound N([C@@H](C)C(=O)N[C@@H]1C(N(C)C2=CC=CC=C2C(C=2C=CC=CC=2)=N1)=O)C(=O)CC1=CC(F)=CC(F)=C1 JNGZXGGOCLZBFB-IVCQMTBJSA-N 0.000 description 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
238000000605 extraction Methods 0.000 description 2
235000011147 magnesium chloride Nutrition 0.000 description 2
229910052748 manganese Inorganic materials 0.000 description 2
238000005259 measurement Methods 0.000 description 2
TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 2
229940045641 monobasic sodium phosphate Drugs 0.000 description 2
238000005192 partition Methods 0.000 description 2
239000013641 positive control Substances 0.000 description 2
WLWIMKWZMGJRBS-UHFFFAOYSA-N primin Chemical compound CCCCCC1=CC(=O)C=C(OC)C1=O WLWIMKWZMGJRBS-UHFFFAOYSA-N 0.000 description 2
235000018102 proteins Nutrition 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
238000011160 research Methods 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
238000000926 separation method Methods 0.000 description 2
AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 2
230000001954 sterilising effect Effects 0.000 description 2
238000004659 sterilization and disinfection Methods 0.000 description 2
239000011550 stock solution Substances 0.000 description 2
125000001424 substituent group Chemical group 0.000 description 2
239000000725 suspension Substances 0.000 description 2
235000011178 triphosphate Nutrition 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 1
AIGNCQCMONAWOL-UHFFFAOYSA-N 1,3-benzoselenazole Chemical compound C1=CC=C2[se]C=NC2=C1 AIGNCQCMONAWOL-UHFFFAOYSA-N 0.000 description 1
AFFLGGQVNFXPEV-UHFFFAOYSA-N 1-decene Chemical group CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 1
SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 1
OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 description 1
MDKGOTTVUWLPLW-UHFFFAOYSA-N 2-phenyl-1h-indole-3,4-diamine Chemical compound N1C2=CC=CC(N)=C2C(N)=C1C1=CC=CC=C1 MDKGOTTVUWLPLW-UHFFFAOYSA-N 0.000 description 1
DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 1
FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
PDDRBNDSMILNJH-UHFFFAOYSA-N 4-[4,5-bis[4-(dimethylamino)phenyl]-1H-imidazol-2-yl]-2-methoxyphenol Chemical compound C1=C(O)C(OC)=CC(C=2NC(=C(N=2)C=2C=CC(=CC=2)N(C)C)C=2C=CC(=CC=2)N(C)C)=C1 PDDRBNDSMILNJH-UHFFFAOYSA-N 0.000 description 1
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
108020000946 Bacterial DNA Proteins 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
241000606161 Chlamydia Species 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
102000004594 DNA Polymerase I Human genes 0.000 description 1
108010017826 DNA Polymerase I Proteins 0.000 description 1
AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
108020000949 Fungal DNA Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
206010020460 Human T-cell lymphotropic virus type I infection Diseases 0.000 description 1
241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
241000714259 Human T-lymphotropic virus 2 Species 0.000 description 1
241000701024 Human betaherpesvirus 5 Species 0.000 description 1
241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
241000701806 Human papillomavirus Species 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
241000186359 Mycobacterium Species 0.000 description 1
QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
229910002651 NO3 Inorganic materials 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
241000607768 Shigella Species 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
239000008051 TBE buffer Substances 0.000 description 1
241001135650 Thermotoga sp. Species 0.000 description 1
241000589596 Thermus Species 0.000 description 1
108020005202 Viral DNA Proteins 0.000 description 1
108020000999 Viral RNA Proteins 0.000 description 1
ZYVSOIYQKUDENJ-ASUJBHBQSA-N [(2R,3R,4R,6R)-6-[[(6S,7S)-6-[(2S,4R,5R,6R)-4-[(2R,4R,5R,6R)-4-[(2S,4S,5S,6S)-5-acetyloxy-4-hydroxy-4,6-dimethyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-7-[(3S,4R)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-4,10-dihydroxy-3-methyl-5-oxo-7,8-dihydro-6H-anthracen-2-yl]oxy]-4-[(2R,4R,5R,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-2-methyloxan-3-yl] acetate Chemical class COC([C@@H]1Cc2cc3cc(O[C@@H]4C[C@@H](O[C@@H]5C[C@@H](O)[C@@H](OC)[C@@H](C)O5)[C@H](OC(C)=O)[C@@H](C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1O[C@H]1C[C@@H](O[C@@H]2C[C@@H](O[C@H]3C[C@](C)(O)[C@@H](OC(C)=O)[C@H](C)O3)[C@H](O)[C@@H](C)O2)[C@H](O)[C@@H](C)O1)C(=O)[C@@H](O)[C@@H](C)O ZYVSOIYQKUDENJ-ASUJBHBQSA-N 0.000 description 1
OTNSELQCFOLCCA-UHFFFAOYSA-N [1,3]thiazolo[4,5-b]quinoline Chemical compound C1=CC=C2C=C(SC=N3)C3=NC2=C1 OTNSELQCFOLCCA-UHFFFAOYSA-N 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
HJLDPBXWNCCXGM-UHFFFAOYSA-N benzo[f][1,3]benzothiazole Chemical compound C1=CC=C2C=C(SC=N3)C3=CC2=C1 HJLDPBXWNCCXGM-UHFFFAOYSA-N 0.000 description 1
125000004057 biotinyl group Chemical group [H]N1C(=O)N([H])[C@]2([H])[C@@]([H])(SC([H])([H])[C@]12[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
SMNPLAKEGAEPJD-UHFFFAOYSA-N chembl34922 Chemical compound Cl.Cl.Cl.C1CN(C)CCN1C1=CC=C(NC(=N2)C=3C=C4N=C(NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 SMNPLAKEGAEPJD-UHFFFAOYSA-N 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
UFJPAQSLHAGEBL-RRKCRQDMSA-N dITP Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(N=CNC2=O)=C2N=C1 UFJPAQSLHAGEBL-RRKCRQDMSA-N 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
238000013461 design Methods 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
238000007720 emulsion polymerization reaction Methods 0.000 description 1
HXQVQGWHFRNKMS-UHFFFAOYSA-M ethylmercurithiosalicylic acid Chemical compound CC[Hg]SC1=CC=CC=C1C(O)=O HXQVQGWHFRNKMS-UHFFFAOYSA-M 0.000 description 1
229940005660 ethylmercurithiosalicylic acid Drugs 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000012530 fluid Substances 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
239000011521 glass Substances 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
SMWDFEZZVXVKRB-UHFFFAOYSA-O hydron;quinoline Chemical compound [NH+]1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-O 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
238000009830 intercalation Methods 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
150000002681 magnesium compounds Chemical class 0.000 description 1
229910001425 magnesium ion Inorganic materials 0.000 description 1
159000000003 magnesium salts Chemical class 0.000 description 1
235000019341 magnesium sulphate Nutrition 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
229910001437 manganese ion Inorganic materials 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
150000004712 monophosphates Chemical class 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
229960003330 pentetic acid Drugs 0.000 description 1
125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
239000013612 plasmid Substances 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
239000012985 polymerization agent Substances 0.000 description 1
239000001103 potassium chloride Substances 0.000 description 1
235000011164 potassium chloride Nutrition 0.000 description 1
238000012545 processing Methods 0.000 description 1
235000019260 propionic acid Nutrition 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 1
244000000040 protozoan parasite Species 0.000 description 1
101150108487 pst2 gene Proteins 0.000 description 1
JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
230000010076 replication Effects 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
XZTJQQLJJCXOLP-UHFFFAOYSA-M sodium;decyl sulfate Chemical compound [Na+].CCCCCCCCCCOS([O-])(=O)=O XZTJQQLJJCXOLP-UHFFFAOYSA-M 0.000 description 1
239000002904 solvent Substances 0.000 description 1
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
ACOJCCLIDPZYJC-UHFFFAOYSA-M thiazole orange Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1=CC=C2C(C=C3N(C4=CC=CC=C4S3)C)=CC=[N+](C)C2=C1 ACOJCCLIDPZYJC-UHFFFAOYSA-M 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Plural Heterocyclic Compounds (AREA)
Luminescent Compositions (AREA)
Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Investigating Or Analysing Biological Materials (AREA)

CA2148140A 1994-04-29 1995-04-28 Homogeneous method for assay of double-stranded nucleic acids using fluorescent dyes and kit useful therein Expired - Lifetime CA2148140C (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US23539694A	1994-04-29	1994-04-29
US08/235,396		1994-04-29

Publications (2)

Publication Number	Publication Date
CA2148140A1 CA2148140A1 (en)	1995-10-30
CA2148140C true CA2148140C (en)	2010-08-10

Family

ID=22885321

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2148140A Expired - Lifetime CA2148140C (en)	1994-04-29	1995-04-28	Homogeneous method for assay of double-stranded nucleic acids using fluorescent dyes and kit useful therein

Country Status (8)

Country	Link
US (1)	US5563037A (de)
EP (1)	EP0684316B1 (de)
JP (1)	JP4260903B2 (de)
KR (1)	KR100388732B1 (de)
CN (1)	CN1100884C (de)
AT (1)	ATE280243T1 (de)
CA (1)	CA2148140C (de)
DE (1)	DE69533660T2 (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7273749B1 (en)	1990-06-04	2007-09-25	University Of Utah Research Foundation	Container for carrying out and monitoring biological processes
US7081226B1 (en)	1996-06-04	2006-07-25	University Of Utah Research Foundation	System and method for fluorescence monitoring
US5935522A (en) *	1990-06-04	1999-08-10	University Of Utah Research Foundation	On-line DNA analysis system with rapid thermal cycling
US6180403B1 (en) *	1999-10-28	2001-01-30	Isis Pharmaceuticals Inc.	Antisense inhibition of tumor necrosis factor alpha converting enzyme (TACE) expression
US5854033A (en)	1995-11-21	1998-12-29	Yale University	Rolling circle replication reporter systems
JP2001501454A (ja) *	1996-05-17	2001-02-06	イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー	プライマーに制御された増幅産物の蛍光検出による標的細菌の同定
SE506700C2 (sv) *	1996-05-31	1998-02-02	Mikael Kubista	Sond och förfaranden för analys av nukleinsyra
JP4540754B2 (ja) *	1996-06-04	2010-09-08	ユニバーシティオブユタリサーチファウンデーション	Ｐｃｒ中のハイブリダイゼーションのモニタリング
US6312930B1 (en)	1996-09-16	2001-11-06	E. I. Du Pont De Nemours And Company	Method for detecting bacteria using PCR
AU6534898A (en) *	1997-02-14	1998-09-08	E.I. Du Pont De Nemours And Company	Detection of double-stranded dna in a homogeneous solution
ES2286750T3 (es)	1998-05-01	2007-12-01	Gen-Probe Incorporated	Dispositivo para agitar el contenido liquido de un contenedor.
US6242188B1 (en)	1999-07-30	2001-06-05	Applied Gene Technologies, Inc.	Sample processing to release nucleic acids for direct detection
JP2003517842A (ja)	1999-12-21	2003-06-03	オーソ−クリニカル・ダイアグノスティックス・インコーポレイテッド	核酸の検出方法
CA2383939C (en)	2000-06-27	2009-12-01	National Institute Of Advanced Industrial Science And Technology	Novel nucleic acid probes, method for determining nucleic acids by using the probes, and method for analyzing data obtained by the method
AU2000267686A1 (en) *	2000-08-10	2002-02-25	Applied Gene Technologies, Inc.	Compositions and methods for nucleic acids sample processing and amplification
US6573051B2 (en) *	2001-03-09	2003-06-03	Molecular Staging, Inc.	Open circle probes with intramolecular stem structures
US7267945B2 (en) *	2001-03-26	2007-09-11	Applera Corporation	Methods of determining the presence of polynucleotides employing amplification
US7297485B2 (en) *	2001-10-15	2007-11-20	Qiagen Gmbh	Method for nucleic acid amplification that results in low amplification bias
US6617137B2 (en) *	2001-10-15	2003-09-09	Molecular Staging Inc.	Method of amplifying whole genomes without subjecting the genome to denaturing conditions
US6977148B2 (en) *	2001-10-15	2005-12-20	Qiagen Gmbh	Multiple displacement amplification
US7553619B2 (en)	2002-02-08	2009-06-30	Qiagen Gmbh	Detection method using dissociated rolling circle amplification
EP1335028B1 (de) *	2002-02-12	2008-01-16	University of Utah Research Foundation	Multi-Test-Analyse von Echzeit-Nukleinsäureamplifikationen
AU2003288906C1 (en)	2002-09-20	2010-12-09	Yale University	Riboswitches, methods for their use, and compositions for use with riboswitches.
CA2501144C (en) *	2002-10-23	2015-10-06	University Of Utah Research Foundation	Amplicon melting analysis with saturation dyes
US9850381B2 (en) *	2002-10-23	2017-12-26	University Of Utah Research Foundation	Amplicon melting analysis with saturation dyes
WO2004041192A2 (en) *	2002-10-31	2004-05-21	Pfizer Products, Inc.	Panels of molecular targets differentially expressed during cd8+ t-cell priming
NZ540288A (en) *	2002-11-22	2009-06-26	Univ Johns Hopkins	Target for therapy of cognitive impairment
US20040121338A1 (en) *	2002-12-19	2004-06-24	Alsmadi Osama A.	Real-time detection of rolling circle amplification products
US9487823B2 (en)	2002-12-20	2016-11-08	Qiagen Gmbh	Nucleic acid amplification
AU2003299694A1 (en)	2002-12-20	2004-07-22	Qiagen Gmbh	Nucleic acid amplification
US7955795B2 (en) *	2003-06-06	2011-06-07	Qiagen Gmbh	Method of whole genome amplification with reduced artifact production
US6977153B2 (en) *	2002-12-31	2005-12-20	Qiagen Gmbh	Rolling circle amplification of RNA
US8043834B2 (en)	2003-03-31	2011-10-25	Qiagen Gmbh	Universal reagents for rolling circle amplification and methods of use
ATE355529T1 (de) *	2003-08-20	2006-03-15	Sysmex Corp	Probenanalysegerät und eine vorrichtung zur detektion von nukleinsäuren
KR100906749B1 (ko) *	2004-03-25	2009-07-09	(주)바이오니아	인터컬레이팅 형광염료가 표지된 프로브를 이용한 핵산 증폭 측정 방법
US9657347B2 (en)	2004-04-20	2017-05-23	University of Utah Research Foundation and BioFire Defense, LLC	Nucleic acid melting analysis with saturation dyes
US7387887B2 (en) *	2004-04-20	2008-06-17	University Of Utah Research Foundation	Nucleic acid melting analysis with saturation dyes
US7776567B2 (en) *	2005-03-17	2010-08-17	Biotium, Inc.	Dimeric and trimeric nucleic acid dyes, and associated systems and methods
US8309303B2 (en)	2005-04-01	2012-11-13	Qiagen Gmbh	Reverse transcription and amplification of RNA with simultaneous degradation of DNA
US20060275798A1 (en) *	2005-04-04	2006-12-07	Steichen John C	Detection of organisms using a media sachet and primer directed nucleic acid amplification
US7456281B2 (en) *	2005-04-20	2008-11-25	Idaho Technology, Inc.	Nucleic acid melting analysis with saturation dyes
US20060246513A1 (en) *	2005-05-02	2006-11-02	Bohannon Robert C	Method and device to detect the presence of analytes in a sample
EP1762627A1 (de)	2005-09-09	2007-03-14	Qiagen GmbH	Verfahren zur Aktivierung einer Nukleinsäure für eine Polymerase-Reaktion
US7781165B2 (en) *	2005-10-19	2010-08-24	Roche Diagnostics Operations, Inc.	Benzimidazolium compounds and salts of benzimidazolium compounds for nucleic acid amplification
WO2007100412A2 (en) *	2005-12-21	2007-09-07	Yale University	Methods and compositions related to the modulation of riboswitches
US20080057499A1 (en) *	2006-02-06	2008-03-06	Affymetrix, Inc.	Methods for high specificity whole genome amplification and hybridization
WO2008033866A2 (en) *	2006-09-11	2008-03-20	Yale University	Methods and compositions for the use of lysine riboswitches
MX2009010081A (es)	2007-03-22	2010-01-20	Univ Yale	Metodos y composiciones relacionadas con los ribointerruptores (riboswitches) que controlan el corte y empalme (splicing) alternativo.
AU2008260089A1 (en) *	2007-05-29	2008-12-11	Yale University	Methods and compositions related to riboswitches that control alternative splicing and RNA processing
EP2164996A4 (de)	2007-05-29	2010-07-14	Univ Yale	Riboswitches sowie verfahren und zusammensetzungen zur verwendung von und mit riboswitches
CA2750820A1 (en)	2009-01-27	2010-08-05	Qiagen Gaithersburg	Thermophilic helicase dependent amplification technology with endpoint homogenous fluorescent detection
WO2010132665A1 (en)	2009-05-15	2010-11-18	Yale University	Gemm riboswitches, structure-based compound design with gemm riboswitches, and methods and compositions for use of and with gemm riboswitches
US8877437B1 (en)	2009-12-23	2014-11-04	Biotium, Inc.	Methods of using dyes in association with nucleic acid staining or detection
EP2524042A2 (de)	2010-01-12	2012-11-21	Yale University	Strukturierte rna-motive sowie verbindungen und verfahren zu ihrer verwendung
WO2011150227A1 (en)	2010-05-26	2011-12-01	Qiagen Gaithersburg, Inc.	Quantitative helicase assay
EP2752668A3 (de)	2010-07-23	2014-10-15	Beckman Coulter, Inc.	System oder Verfahren zur Aufnahme analytischer Einheiten
WO2012021554A1 (en)	2010-08-09	2012-02-16	Yale University	Cyclic di-gmp-ii riboswitches, motifs, and compounds, and methods for their use
CN102095705A (zh) *	2010-12-09	2011-06-15	山东理工大学	一种基于激光扫描共聚焦显微镜的头发丝成像方法
US9580713B2 (en)	2011-09-17	2017-02-28	Yale University	Fluoride-responsive riboswitches, fluoride transporters, and methods of use
ES2778054T3 (es)	2011-11-07	2020-08-07	Beckman Coulter Inc	Sistema y método para transportar recipientes de muestras
CN104040357B (zh)	2011-11-07	2016-11-23	贝克曼考尔特公司	等分器系统以及工作流
KR20140091032A (ko)	2011-11-07	2014-07-18	베크만 컬터, 인코포레이티드	검체 수송 시스템의 자기 감쇠
WO2013070755A2 (en)	2011-11-07	2013-05-16	Beckman Coulter, Inc.	Centrifuge system and workflow
KR20140091033A (ko)	2011-11-07	2014-07-18	베크만 컬터, 인코포레이티드	검체 컨테이너 검출
US9446418B2 (en)	2011-11-07	2016-09-20	Beckman Coulter, Inc.	Robotic arm
WO2014152775A2 (en)	2013-03-14	2014-09-25	Certirx Corporation	Nucleic acid-based authentication and identification codes
CN110426442B (zh) *	2016-06-13	2022-02-11	苏州优逸兰迪生物科技有限公司	一种核酸凝胶电泳测试的方法
US10427162B2 (en)	2016-12-21	2019-10-01	Quandx Inc.	Systems and methods for molecular diagnostics

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4257774A (en) *	1979-07-16	1981-03-24	Meloy Laboratories, Inc.	Intercalation inhibition assay for compounds that interact with DNA or RNA
US4544546A (en) *	1980-04-21	1985-10-01	Abbott Laboratories	Fluorescent nucleic acid stains
CA1155041A (en) *	1980-04-21	1983-10-11	Michael E. Jolley	Fluorescent nucleic acid stains
US4777129A (en) *	1983-12-12	1988-10-11	Molecular Diagnostics, Inc.	Nucleic acid probe detectable by specific nucleic acid binding protein
US5026840A (en) *	1985-01-10	1991-06-25	Molecular Diagnostics, Inc.	Photochemical nucleic acid-labeling reagent having a polyalklamine spacer
US4883867A (en) *	1985-11-01	1989-11-28	Becton, Dickinson And Company	Detection of reticulocytes, RNA or DNA
US4957870A (en) *	1985-11-01	1990-09-18	Becton, Dickinson And Company	Detection of Reticulocytes, RNA and DNA
US5242797A (en) *	1986-03-21	1993-09-07	Myron J. Block	Nucleic acid assay method
US5047321A (en) *	1988-06-15	1991-09-10	Becton Dickinson & Co.	Method for analysis of cellular components of a fluid
US4937198A (en) *	1989-07-28	1990-06-26	Becton, Dickinson And Company	Novel fluorescent dye
US5049490A (en) *	1990-02-20	1991-09-17	Eastman Kodak Co.	Quantitative determination of a DNA polymerase and a test kit useful in same
US5312921A (en) *	1990-03-14	1994-05-17	Regents Of The University Of California	Dyes designed for high sensitivity detection of double-stranded DNA
CA2078006C (en) *	1990-03-14	2002-02-05	Alexander Namiot Glazer	Multichromophore fluorescent probes
DE69128520T2 (de) *	1990-10-31	1998-07-09	Tosoh Corp	Verfahren zum Nachweis oder Quantifizierung von Zielnukleinsäuren
US5994056A (en) *	1991-05-02	1999-11-30	Roche Molecular Systems, Inc.	Homogeneous methods for nucleic acid amplification and detection
JPH0540097A (ja) *	1991-08-06	1993-02-19	Hitachi Chem Co Ltd	蛍光標識用色素、蛍光標識用色素で標識された生物由来物質、及びそれらを含有する試薬
US5316906A (en) *	1991-08-23	1994-05-31	Molecular Probes, Inc.	Enzymatic analysis using substrates that yield fluorescent precipitates
CA2119126C (en) *	1991-09-16	1996-09-03	Molecular Probes, Inc.	Dimers of unsymmetrical cyanine dyes
US5321130A (en) *	1992-02-10	1994-06-14	Molecular Probes, Inc.	Unsymmetrical cyanine dyes with a cationic side chain

1995
- 1995-04-28 EP EP95302921A patent/EP0684316B1/de not_active Expired - Lifetime
- 1995-04-28 CA CA2148140A patent/CA2148140C/en not_active Expired - Lifetime
- 1995-04-28 DE DE69533660T patent/DE69533660T2/de not_active Expired - Lifetime
- 1995-04-28 AT AT95302921T patent/ATE280243T1/de not_active IP Right Cessation
- 1995-04-29 CN CN95106515A patent/CN1100884C/zh not_active Expired - Lifetime
- 1995-04-29 KR KR1019950010417A patent/KR100388732B1/ko not_active Expired - Fee Related
- 1995-05-01 JP JP10746895A patent/JP4260903B2/ja not_active Expired - Fee Related
- 1995-12-21 US US08/576,861 patent/US5563037A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US5563037A (en)	1996-10-08
CA2148140A1 (en)	1995-10-30
KR950032641A (ko)	1995-12-22
KR100388732B1 (ko)	2004-09-04
ATE280243T1 (de)	2004-11-15
JPH0889299A (ja)	1996-04-09
DE69533660D1 (de)	2004-11-25
JP4260903B2 (ja)	2009-04-30
CN1100884C (zh)	2003-02-05
CN1114359A (zh)	1996-01-03
EP0684316B1 (de)	2004-10-20
DE69533660T2 (de)	2005-11-10
EP0684316A1 (de)	1995-11-29

Legal Events

Date	Code	Title	Description
2002-04-25	EEER	Examination request
2015-06-30	MKEX	Expiry	Effective date: 20150428

Publication	Publication Date	Title
CA2148140C (en)	2010-08-10	Homogeneous method for assay of double-stranded nucleic acids using fluorescent dyes and kit useful therein
EP0702090B1 (de)	2004-05-06	Verfahren zur Koamplifikation einer Zielnukleinsäure unter Versendung eines Volumenabscheidungsmittel in der Reaktionszusammensetzung, Testsatz und Testvorrichtung
US5482834A (en)	1996-01-09	Evaluation of nucleic acids in a biological sample hybridization in a solution of chaotrophic salt solubilized cells
US6475729B1 (en)	2002-11-05	Nucleic acid amplification and detection methods using rapid polymerase chain reaction cycle
EP0521111B1 (de)	1998-11-18	Polynukleotid-einfang-assay unter verwendung von in-vitro-amplifikation
US5403707A (en)	1995-04-04	Diagnostic compositions, elements, methods and test kits for amplification and detection of retroviral DNA using primers having matched melting temperatures
US5702901A (en)	1997-12-30	Diagnostic compositions, elements, methods and test kits for amplification and detection of two or more DNA's using primers having matched melting temperatures
US5196305A (en)	1993-03-23	Diagnostic and amplification methods using primers having thymine at 3' end to overcome primer-target mismatch at the 3' end
JPH03206898A (ja)	1991-09-10	クラミジア・トラコーマチスの検出方法およびそのためのキット
US5674717A (en)	1997-10-07	Rapid method for preferential coamplification of two different nucleic acid sequences using polymerase chain reaction
CA2199213C (en)	2007-04-17	Amplifying and detecting target nucleic acids using a post amplification incubation step
US5559013A (en)	1996-09-24	Method of amplification using intermediate renaturation step
EP0677589B1 (de)	2001-05-16	Verfahren, Testelement und Testsatz zum halbquantitativen Nachweis von Nukleinsäure
CA2024978A1 (en)	1991-03-23	Nucleic acid detection method using unequal primer concentrations in polymerase chain reaction
JPH07298897A (ja)	1995-11-14	２つの標識プライマーを用いた標的核酸の生成、増幅及び検出方法並びにそれらを含有するｐｃｒキット
HK1004861B (en)	2001-10-26	Nucleic acid amplification and detection methods using rapid polymerase chain reaction cycle